Abstract
Groundbreaking progress has been recently made in elucidating the signaling pathways that are altered in adrenocortical carcinoma (ACC), an endocrine malignancy that still has an unfavorable prognosis, and in understanding its genomic structure. These advances need now to be translated to create cellular and animal models more relevant to human disease in order to develop new and more effective diagnostic procedures and targeted therapies against this deadly malignancy.
Original language | English |
---|---|
Pages (from-to) | 44-48 |
Number of pages | 5 |
Journal | Hormones and Cancer |
Volume | 7 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2016 Feb 1 |
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Oncology
- Endocrinology
- Endocrine and Autonomic Systems
- Cancer Research